Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease
2d agoen
From the article
Conditions : Kawasaki Disease Interventions : Drug: IVIG; Drug: Aspirin; Drug: Firsekibart Sponsors : Children's Hospital of Fudan University; Jiangxi Province Children's Hospital Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Acute versus Long-term anti-GPVI Treatment: From Receptor Blockade to Partial Downregulation
communities.springernature.com·18h ago
以岭药业：厄贝沙坦化学原料药上市申请获批
36氪·2d ago
Realizing the potential of agonistic antibody immunotherapy
doi.org·16d ago
https://doi.org/10.1056/NEJMoa2517384
doi.org·1mo ago
Four JAK Inhibitors Show Positive Late-Stage Trial Results for Axial Spondyloarthritis Treatment
Positive results from late-stage clinical trials of four JAK inhibitors (filgotinib, gecacitinib, ivarmacitinib, and tofacitinib) for treati
mdsc.pe·17d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.